Zacks Research Downgrades Integer (NYSE:ITGR) to Strong Sell

Integer (NYSE:ITGR) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Monday,Zacks.com reports.

Several other equities research analysts have also recently commented on ITGR. Citigroup cut their price objective on shares of Integer from $92.00 to $89.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Wall Street Zen cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Wells Fargo & Company boosted their price objective on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, February 20th. Raymond James Financial reaffirmed an “outperform” rating and issued a $101.00 price objective on shares of Integer in a research report on Monday, February 23rd. Finally, Truist Financial boosted their price objective on shares of Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Friday, February 20th. Four investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Integer has a consensus rating of “Hold” and a consensus target price of $98.29.

Integer Price Performance

ITGR opened at $85.15 on Monday. The company has a fifty day moving average price of $86.07 and a two-hundred day moving average price of $80.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. Integer has a 52 week low of $62.00 and a 52 week high of $123.78. The firm has a market capitalization of $2.89 billion, a PE ratio of 21.23, a P/E/G ratio of 1.47 and a beta of 0.67.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The firm had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The company’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, analysts anticipate that Integer will post 6.11 earnings per share for the current year.

Insider Buying and Selling

In related news, VP Tommy P. Thomas sold 825 shares of the company’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the transaction, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This represents a 15.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.10% of the company’s stock.

Institutional Trading of Integer

A number of institutional investors have recently bought and sold shares of the business. Salomon & Ludwin LLC increased its stake in Integer by 46.8% during the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 118 shares during the period. Kestra Advisory Services LLC increased its stake in shares of Integer by 0.6% during the fourth quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock worth $1,680,000 after buying an additional 136 shares during the period. Orion Porfolio Solutions LLC increased its stake in shares of Integer by 1.4% during the second quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after buying an additional 138 shares during the period. Lido Advisors LLC increased its stake in shares of Integer by 5.5% during the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after buying an additional 151 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of Integer by 9.2% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 1,979 shares of the medical equipment provider’s stock worth $205,000 after buying an additional 166 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.